Inventor · disambiguated record
Changping Jiao
Also filed as: JIAO CHANGPING
0 granted patents·6 pending applications·0 citations·filing 2020–2022
Files withNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD4JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD1NUO BETA PHARMACEUTICAL TECH SHANGHAIA CO LTD1
Top patents by PatentIndex Score
6 records- 0153US2024050395A1Deuterated oxophenylarsine compound and use thereofNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0253US2024391942A1Halogenated phenylarsine oxide compound and application thereofNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0349US2024261250A1Applications of p14k inhibitor in intracellular protein misfolding-related diseases and lysosomal storage diseasesNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0444US2023115711A1MICROMOLECULE PI4KIIIalpha INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOFNUO BETA PHARMACEUTICAL TECH SHANGHAIA CO LTD·Filed 2020·Application pending·0 cites
- 0542US2025152599A1Anti-coronavirus effect and application of p14k inhibitorNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0635US2022362203A1Method for treating mood disordersJIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Changping Jiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →